Crawford & Comp D (CRDB)

Crawford & Company is a NYSE-listed common stock issuer in the financials sector, operating through its insurance-related claims management business. The company provides claims management and outsourcing services for carriers, brokers, corporations, and self-insured entities across the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. Its services include claims adjusting and resolution for property and casualty exposures, as well as coverage areas such as property, public liability, automobile liability, marine, workers’ compensation, disability, life, critical illness, and credit protection claims. Crawford & Company also supports risk management, legal and analytical services, loss mitigation, managed repair, contractor management, staff augmentation, and subrogation services. Founded in 1941, the company is headquartered in Atlanta, Georgia.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CRD.B
$15.25
30.9% Upside
Undervalued
$14
20.2% Upside
Undervalued
Fair
2.8%
November 9, 2026
24.8x
3.1x
0.5x
583.2 M
782.6 M
31.8%
46.5%
4.3
62.6%
408.5%
Valuation • Fair Value

Crawford & Comp D (NYSE-CRD.B) Fair Value by Valuation Model

Review the available estimates for Crawford & Comp D (NYSE-CRD.B), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$15.25

Estimated upside of 30.9% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$19.07

Discounted cash flow valuation reference.

Ben Graham Formula Value

$5.37

Classic Ben Graham valuation formula reference.

DDM Fair Value

$15.75

Dividend discount model valuation reference.

EPV Fair Value

$13.45

Earnings power value estimate.

Comps Fair Value

$11.55

Comparable-company valuation reference.

Analyst Price Target

$14

Analysts imply upside of 20.2%.

How to read these valuation models

Use the 8 available valuation references for Crawford & Comp D (NYSE-CRD.B) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Crawford & Comp D (NYSE-CRD.B)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.262 B

Current operating scale indicator.

Revenue Forecast

1.28 B

Forward revenue estimate.

EBITDA

79.814 M

Current operating profitability reference.

EBITDA Forecast

123.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Crawford & Comp D (NYSE-CRD.B) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Crawford & Comp D (NYSE-CRD.B)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-3.06

No elevated caution signal from this screen.

Altman Z-Score

4.3

Relatively strong balance-sheet zone.

FCF / Net Income

408.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Crawford & Comp D (NYSE-CRD.B). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Crawford & Comp D (NYSE-CRD.B)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 9, 2026

Days to Earnings

53

Dividend Yield

2.8%

Current income yield reference.

Payout Ratio

62.6%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Crawford & Comp D (NYSE-CRD.B), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Crawford & Comp D (NYSE-CRD.B) Stock Forecast & Technical Outlook

Review Crawford & Comp D (NYSE-CRD.B) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Crawford & Comp D (NYSE-CRD.B) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Crawford & Comp D (NYSE-CRD.B) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Crawford & Comp D (NYSE-CRD.B) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Crawford & Comp D (NYSE-CRD.B) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Crawford & Comp D (NYSE-CRD.B) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Crawford & Comp D (NYSE-CRD.B)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Crawford & Comp D (NYSE-CRD.B) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ Fast Investor Answers

Crawford & Comp D (NYSE-CRD.B) Stock FAQ

Data-supported answers about Crawford & Comp D (NYSE-CRD.B), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$15.25
Estimated upside 30.9%
Valuation Rating
Undervalued
Estimated upside of 30.9%
Analyst Target
$14
Implied upside 20.2%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Crawford & Comp D (NYSE-CRD.B) is $15.25. This implies an estimated upside of 30.9% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 30.9% versus the current market price.

The available analyst price target for Crawford & Comp D (NYSE-CRD.B) is $14. The analyst target implies estimated upside of 20.2%.

The current financial health read for Crawford & Comp D (NYSE-CRD.B) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Crawford & Comp D (NYSE-CRD.B) is November 9, 2026.

Based on the current data, dividend yield is 2.8%.

The current P/E ratio listed for Crawford & Comp D (NYSE-CRD.B) is 24.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Crawford & Comp D is 583.2 M.

The current enterprise value listed for Crawford & Comp D is 782.6 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Crawford & Comp D is NYSE-CRD.B, and the stock is listed on NYSE.

Crawford & Comp D (NYSE-CRD.B) is listed on NYSE.

The current debt-to-total-capital ratio listed for Crawford & Comp D is 31.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Crawford & Comp D is 46.5%. Free float helps investors understand how much of the share base is available for public trading.